お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は髄膜炎菌市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは髄膜炎菌の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の髄膜炎菌市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは髄膜炎菌のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に髄膜炎菌市場を分類しています。本研究に含まれる主な企業は：Sanofi Pasteur、Pfizer、Glaxo Smith Kline、Hualan Biological Engineering、JN International Medical Corporation、Baxter International、Merck、Serum Institute of India、Biomed、Novartis

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Menactra
    Menveo
    NeisVac-C
    Nimenrix
    Others

用途別の市場セグメント：
    Children
    Preteens or Teens
    Adults

本レポートの詳細内容
世界の髄膜炎菌市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、髄膜炎菌タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の髄膜炎菌収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の髄膜炎菌市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、髄膜炎菌市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

髄膜炎菌のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：髄膜炎菌のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：髄膜炎菌の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章髄膜炎菌企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：髄膜炎菌の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：髄膜炎菌の主要企業の概要を提供し、製品の説明と仕様、髄膜炎菌の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.
Market Analysis and Insights: Global Meningococcal Conjugate Market
The global Meningococcal Conjugate market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Meningococcal Conjugate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Meningococcal Conjugate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Meningococcal Conjugate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Meningococcal Conjugate include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Meningococcal Conjugate is widely used in various fields, such as Children, Preteens or Teens and Adults,, etc. Children provides greatest supports to the Meningococcal Conjugate industry development. In 2023, global % revenue of Meningococcal Conjugate went into Children filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Meningococcal Conjugate market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Meningococcal Conjugate, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Meningococcal Conjugate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Meningococcal Conjugate revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Meningococcal Conjugate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by End User, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Meningococcal Conjugate revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc.

Market Segmentation
By Company
    Sanofi Pasteur
    Pfizer
    Glaxo Smith Kline
    Hualan Biological Engineering
    JN International Medical Corporation
    Baxter International
    Merck
    Serum Institute of India
    Biomed
    Novartis

Segment by Type
    Menactra
    Menveo
    NeisVac-C
    Nimenrix
    Others

Segment by End User
    Children
    Preteens or Teens
    Adults

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Meningococcal Conjugate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningococcal Conjugate companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by End User and by country, revenue for each segment.
Chapter 7: Europe by Type, by End User and by country, revenue for each segment.
Chapter 8: China by Type, and by End User, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by End User and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by End User and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Meningococcal Conjugate revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Menactra
    Table 3. Key Players of Menveo
    Table 4. Key Players of NeisVac-C
    Table 5. Key Players of Nimenrix
    Table 6. Key Players of Others
    Table 7. Global Meningococcal Conjugate Market Size Growth Rate by End User (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Meningococcal Conjugate Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Meningococcal Conjugate Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Meningococcal Conjugate Market Share by Region (2019-2024)
    Table 11. Global Meningococcal Conjugate Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Meningococcal Conjugate Market Share by Region (2025-2030)
    Table 13. Meningococcal Conjugate Market Trends
    Table 14. Meningococcal Conjugate Market Drivers
    Table 15. Meningococcal Conjugate Market Challenges
    Table 16. Meningococcal Conjugate Market Restraints
    Table 17. Global Meningococcal Conjugate Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Meningococcal Conjugate Revenue Share by Players (2019-2024)
    Table 19. Global Top Meningococcal Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2023)
    Table 20. Global Meningococcal Conjugate Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Meningococcal Conjugate, Headquarters and Area Served
    Table 23. Global Key Players of Meningococcal Conjugate, Product and Application
    Table 24. Global Key Players of Meningococcal Conjugate, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Meningococcal Conjugate Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2019-2024)
    Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2025-2030)
    Table 30. Global Meningococcal Conjugate Market Size by End User (2019-2024) & (US$ Million)
    Table 31. Global Meningococcal Conjugate Revenue Share by End User (2019-2024)
    Table 32. Global Meningococcal Conjugate Forecasted Market Size by End User (2025-2030) & (US$ Million)
    Table 33. Global Meningococcal Conjugate Revenue Share by End User (2025-2030)
    Table 34. North America Meningococcal Conjugate Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Meningococcal Conjugate Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Meningococcal Conjugate Market Size by End User (2019-2024) & (US$ Million)
    Table 37. North America Meningococcal Conjugate Market Size by End User (2025-2030) & (US$ Million)
    Table 38. North America Meningococcal Conjugate Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Meningococcal Conjugate Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Meningococcal Conjugate Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Meningococcal Conjugate Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Meningococcal Conjugate Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Meningococcal Conjugate Market Size by End User (2019-2024) & (US$ Million)
    Table 44. Europe Meningococcal Conjugate Market Size by End User (2025-2030) & (US$ Million)
    Table 45. Europe Meningococcal Conjugate Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Meningococcal Conjugate Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Meningococcal Conjugate Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Meningococcal Conjugate Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Meningococcal Conjugate Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Meningococcal Conjugate Market Size by End User (2019-2024) & (US$ Million)
    Table 51. China Meningococcal Conjugate Market Size by End User (2025-2030) & (US$ Million)
    Table 52. Asia Meningococcal Conjugate Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Meningococcal Conjugate Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Meningococcal Conjugate Market Size by End User (2019-2024) & (US$ Million)
    Table 55. Asia Meningococcal Conjugate Market Size by End User (2025-2030) & (US$ Million)
    Table 56. Asia Meningococcal Conjugate Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Meningococcal Conjugate Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Meningococcal Conjugate Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by End User (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by End User (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Meningococcal Conjugate Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Sanofi Pasteur Company Details
    Table 67. Sanofi Pasteur Business Overview
    Table 68. Sanofi Pasteur Meningococcal Conjugate Product
    Table 69. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 70. Sanofi Pasteur Recent Developments
    Table 71. Pfizer Company Details
    Table 72. Pfizer Business Overview
    Table 73. Pfizer Meningococcal Conjugate Product
    Table 74. Pfizer Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 75. Pfizer Recent Developments
    Table 76. Glaxo Smith Kline Company Details
    Table 77. Glaxo Smith Kline Business Overview
    Table 78. Glaxo Smith Kline Meningococcal Conjugate Product
    Table 79. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 80. Glaxo Smith Kline Recent Developments
    Table 81. Hualan Biological Engineering Company Details
    Table 82. Hualan Biological Engineering Business Overview
    Table 83. Hualan Biological Engineering Meningococcal Conjugate Product
    Table 84. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 85. Hualan Biological Engineering Recent Developments
    Table 86. JN International Medical Corporation Company Details
    Table 87. JN International Medical Corporation Business Overview
    Table 88. JN International Medical Corporation Meningococcal Conjugate Product
    Table 89. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 90. JN International Medical Corporation Recent Developments
    Table 91. Baxter International Company Details
    Table 92. Baxter International Business Overview
    Table 93. Baxter International Meningococcal Conjugate Product
    Table 94. Baxter International Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 95. Baxter International Recent Developments
    Table 96. Merck Company Details
    Table 97. Merck Business Overview
    Table 98. Merck Meningococcal Conjugate Product
    Table 99. Merck Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 100. Merck Recent Developments
    Table 101. Serum Institute of India Company Details
    Table 102. Serum Institute of India Business Overview
    Table 103. Serum Institute of India Meningococcal Conjugate Product
    Table 104. Serum Institute of India Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 105. Serum Institute of India Recent Developments
    Table 106. Biomed Company Details
    Table 107. Biomed Business Overview
    Table 108. Biomed Meningococcal Conjugate Product
    Table 109. Biomed Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 110. Biomed Recent Developments
    Table 111. Novartis Company Details
    Table 112. Novartis Business Overview
    Table 113. Novartis Meningococcal Conjugate Product
    Table 114. Novartis Revenue in Meningococcal Conjugate Business (2019-2024) & (US$ Million)
    Table 115. Novartis Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Meningococcal Conjugate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Meningococcal Conjugate Market Share by Type: 2023 VS 2030
    Figure 3. Menactra Features
    Figure 4. Menveo Features
    Figure 5. NeisVac-C Features
    Figure 6. Nimenrix Features
    Figure 7. Others Features
    Figure 8. Global Meningococcal Conjugate Market Size Growth Rate by End User, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Meningococcal Conjugate Market Share by End User: 2023 VS 2030
    Figure 10. Children Case Studies
    Figure 11. Preteens or Teens Case Studies
    Figure 12. Adults Case Studies
    Figure 13. Meningococcal Conjugate Report Years Considered
    Figure 14. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Meningococcal Conjugate Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Meningococcal Conjugate Market Share by Region: 2023 VS 2030
    Figure 17. Global Meningococcal Conjugate Market Share by Players in 2023
    Figure 18. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2023
    Figure 20. North America Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Meningococcal Conjugate Market Share by Type (2019-2030)
    Figure 22. North America Meningococcal Conjugate Market Share by End User (2019-2030)
    Figure 23. North America Meningococcal Conjugate Market Share by Country (2019-2030)
    Figure 24. United States Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Meningococcal Conjugate Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Meningococcal Conjugate Market Share by Type (2019-2030)
    Figure 28. Europe Meningococcal Conjugate Market Share by End User (2019-2030)
    Figure 29. Europe Meningococcal Conjugate Market Share by Country (2019-2030)
    Figure 30. Germany Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Meningococcal Conjugate Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Meningococcal Conjugate Market Share by Type (2019-2030)
    Figure 38. China Meningococcal Conjugate Market Share by End User (2019-2030)
    Figure 39. Asia Meningococcal Conjugate Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Meningococcal Conjugate Market Share by Type (2019-2030)
    Figure 41. Asia Meningococcal Conjugate Market Share by End User (2019-2030)
    Figure 42. Asia Meningococcal Conjugate Market Share by Region (2019-2030)
    Figure 43. Japan Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by End User (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by Country (2019-2030)
    Figure 53. Brazil Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Meningococcal Conjugate Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 61. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 62. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 63. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 64. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 65. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 66. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 67. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 68. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed